Bulimia Nervosa
Summary
Bulimia Nervosa (BN) is a serious eating disorder characterized by recurrent episodes of binge eating followed by compensatory behaviours to prevent weight gain, including self-induced vomiting, laxative/diuretic misuse, fasting, or excessive exercise. Unlike anorexia nervosa, individuals with bulimia typically maintain a normal or slightly above-normal body weight, which often delays recognition. BN carries significant medical risks including electrolyte disturbances (particularly hypokalaemia), dental erosion, and oesophageal complications. Lifetime prevalence is 1-2% in women, with peak onset in late adolescence. CBT-ED is the first-line treatment with high success rates, and high-dose fluoxetine is an effective adjunctive pharmacotherapy.
Key Facts
- Definition: Recurrent binge eating (at least once weekly for 3 months) with compensatory behaviours
- Prevalence: 1-2% lifetime prevalence in women; 0.1-0.5% in men
- Peak onset: 15-20 years (later than anorexia nervosa)
- Weight: Usually normal BMI (18.5-25) — distinguishes from anorexia nervosa
- Key complication: Hypokalaemia from vomiting (can cause cardiac arrhythmias)
- First-line treatment: CBT-ED (Cognitive Behavioural Therapy for Eating Disorders)
- Medication: Fluoxetine 60mg daily reduces binge frequency by 50%
Clinical Pearls
Russell's Sign: Calluses and scarring on the dorsum of the hand/knuckles from repeated self-induced vomiting. Named after Gerald Russell who first described bulimia nervosa in 1979.
The "Normal Weight" Trap: Unlike anorexia nervosa, patients with bulimia typically have normal BMI. This leads to delayed diagnosis — average delay is 5-10 years. Always ask about eating behaviours regardless of weight.
Electrolyte Pattern: Hypokalaemic hypochloraemic metabolic alkalosis is pathognomonic of vomiting. If you see this pattern unexpectedly, consider covert purging.
Why This Matters Clinically
Bulimia nervosa has significant mortality (standardised mortality ratio 1.9) and morbidity, yet is often undetected due to normal weight and secretive behaviours. Early recognition enables effective treatment — CBT-ED achieves remission in 40-50% and significant improvement in another 30%. Medical complications including cardiac arrhythmias from hypokalaemia are preventable with timely intervention.
Incidence & Prevalence
- Lifetime prevalence: 1-2% in women; 0.1-0.5% in men
- Peak incidence: Late adolescence to early twenties (15-25 years)
- 12-month prevalence: 0.3-0.5%
- Trend: Stable over recent decades
Demographics
| Factor | Details |
|---|---|
| Age | Peak onset 15-20 years (later than anorexia) |
| Sex | Female:Male ratio 10:1 |
| Ethnicity | All ethnic groups; possibly higher in Western cultures |
| Geography | More prevalent in developed countries |
| Socioeconomic | All socioeconomic groups affected |
Risk Factors
Non-Modifiable:
- Female sex
- Family history of eating disorders (heritability 28-83%)
- Childhood obesity or early puberty
- Type 1 diabetes (diabulimia)
- Genetic variants affecting serotonin and dopamine pathways
Modifiable:
| Risk Factor | Relative Risk |
|---|---|
| Dieting/weight loss attempts | 3-8x |
| History of childhood sexual abuse | 2-3x |
| Participation in weight-focused sports/activities | 2-4x |
| Body dissatisfaction | 3-5x |
| Peer/media influence regarding thinness | 1.5-2x |
Mechanism
Step 1: Dietary Restraint and Body Dissatisfaction
- Sociocultural pressure for thinness combined with body dissatisfaction
- Strict dieting leads to physiological hunger and psychological deprivation
- Serotonergic dysfunction contributes to poor impulse control
Step 2: The Binge Episode
- Breakdown of dietary restraint triggers binge eating
- Rapid consumption of large amounts of food (typically 2000-5000 kcal)
- Subjective loss of control — cannot stop eating
- Foods chosen are typically "forbidden" high-calorie items
- Dissociation and altered consciousness may occur
Step 3: Guilt and Compensatory Behaviours
- Intense guilt, shame, and fear of weight gain after binge
- Compensatory "purging" behaviours initiated:
- Self-induced vomiting (most common, 80-90%)
- Laxative misuse (60%)
- Diuretic misuse (30%)
- Excessive exercise (fasting less common in BN vs AN)
Step 4: Maintenance Cycle
- Purging provides temporary relief but reinforces cycle
- Vomiting causes metabolic alkalosis and hypokalaemia
- Rebound hypoglycaemia and fluid shifts perpetuate hunger
- Shame leads to secrecy and delayed help-seeking
Classification
| Subtype | Definition | Features |
|---|---|---|
| Purging type | Regular self-induced vomiting, laxatives, diuretics | 80-90% of cases; higher medical risk |
| Non-purging type | Compensates via fasting or excessive exercise only | 10-20%; lower acute medical risk |
DSM-5 Severity Rating
| Severity | Compensatory Behaviours/Week |
|---|---|
| Mild | 1-3 episodes |
| Moderate | 4-7 episodes |
| Severe | 8-13 episodes |
| Extreme | ≥14 episodes |
Physiological Considerations
- Serotonergic dysfunction: Explains both binge eating (impulsivity) and mood symptoms
- Cholecystokinin (CCK) and satiety signals: Abnormal in bulimia, contributing to binge size
- Reward pathway alterations: Dopaminergic changes similar to addiction
- HPA axis: Often dysregulated with elevated cortisol
Symptoms
Typical Presentation:
Associated Symptoms:
Atypical Presentations:
Signs
Oral and Facial:
Skin:
General:
Red Flags
[!CAUTION] Red Flags — Urgent assessment required if:
- Severe hypokalaemia (K+ less than 2.5 mmol/L) — risk of arrhythmias
- Cardiac symptoms (palpitations, syncope)
- Haematemesis (Mallory-Weiss tear or Boerhaave syndrome)
- Active suicidal ideation or intent
- Seizures (electrolyte-related)
- Syncope
- Severe dehydration (dry mucous membranes, hypotension, tachycardia)
Structured Approach
General:
- Weight and BMI (usually normal 18.5-25)
- Vital signs: postural BP drop, tachycardia
- Hydration status: mucous membranes, skin turgor
HEADSSS Assessment (Adolescents):
- Home, Education, Activities, Drugs, Sexuality, Suicide/self-harm, Safety
Oral Examination:
- Dental erosion (lingual surfaces of upper incisors)
- Parotid swelling (bilateral, non-tender)
- Pharyngeal erythema
Hands:
- Russell's sign (calluses on knuckles)
- Peripheral oedema
Cardiac:
- Heart rate and rhythm
- Blood pressure (lying and standing)
Mental State Examination:
- Mood (depression, anxiety common)
- Self-harm/suicidal ideation screening
- Body image and weight overvaluation
- Motivation and insight
Special Tests
| Test | Technique | Positive Finding | Clinical Significance |
|---|---|---|---|
| Postural BP | Lying → standing BP | Drop greater than 20/10 mmHg | Dehydration |
| Russell's sign | Inspect knuckles | Calluses/scarring | Evidence of self-induced vomiting |
| Dental exam | Inspect teeth (lingual surfaces) | Enamel erosion | Acid exposure from vomiting |
| Parotid palpation | Palpate angle of jaw bilaterally | Firm, non-tender swelling | Sialadenosis from repeated vomiting |
| SCOFF questionnaire | 5 screening questions | Score ≥2 positive | 85% sensitivity for eating disorders |
SCOFF Screening Questionnaire
- S: Do you make yourself Sick because you feel uncomfortably full?
- C: Do you worry you have lost Control over how much you eat?
- O: Have you recently lost One stone (6.35 kg) in a 3-month period?
- F: Do you believe yourself to be Fat when others say you are too thin?
- F: Would you say that Food dominates your life?
Score ≥2 = positive screen; sensitivity 85%, specificity 90%
First-Line (Bedside)
- Observations — HR, BP (lying and standing), temperature
- BMI — Usually normal (18.5-25)
- Urinalysis — Specific gravity (dehydration), ketones
Laboratory Tests
| Test | Expected Finding | Purpose |
|---|---|---|
| U&Es | Hypokalaemia, hyponatraemia, metabolic alkalosis | Purging complications |
| Bicarbonate | Elevated (from vomiting) or low (laxative abuse) | Distinguish purging type |
| Chloride | Low (vomiting) | Purging marker |
| Magnesium | May be low | Supplements may be needed |
| Phosphate | Usually normal; monitor in refeeding | Refeeding risk |
| FBC | Usually normal | Exclude anaemia |
| LFTs | Usually normal; may be elevated in severe cases | Liver function |
| TFTs | Usually normal | Exclude thyroid disease |
| Glucose | May be low after binge-purge | Hypoglycaemia |
| Amylase | May be elevated (salivary) | Parotid involvement from vomiting |
Imaging and Other Tests
| Modality | Findings | Indication |
|---|---|---|
| ECG | U waves, prolonged QTc, T wave changes | If hypokalaemia or cardiac symptoms |
| DEXA scan | Reduced bone density | If prolonged illness (greater than 2 years) or amenorrhoea |
| Dental referral | Enamel erosion | If evidence of vomiting |
Diagnostic Criteria
DSM-5 Criteria for Bulimia Nervosa:
- Recurrent episodes of binge eating:
- Eating in a discrete period an amount of food definitely larger than most people would eat
- Sense of lack of control over eating during the episode
- Recurrent inappropriate compensatory behaviours to prevent weight gain (vomiting, laxatives, diuretics, fasting, excessive exercise)
- Binge eating and compensatory behaviours both occur, on average, at least once a week for 3 months
- Self-evaluation is unduly influenced by body shape and weight
- The disturbance does not occur exclusively during episodes of anorexia nervosa
Management Algorithm
Conservative Management
- Psychoeducation: Explain binge-purge cycle and its self-perpetuating nature
- Nutritional counselling: Regular meal pattern (3 meals + 2-3 snacks)
- Self-monitoring: Food and mood diary
- Dental care: Advise against brushing immediately after vomiting (spreads acid); rinse with water or sodium bicarbonate instead
- Harm reduction: If unable to stop purging, advise oral rehydration and potassium-rich foods
Medical Management
| Drug Class | Drug | Dose | Duration |
|---|---|---|---|
| SSRI | Fluoxetine | 60mg once daily | At least 6-12 months |
| Alternative SSRI | Sertraline | 100-200mg daily | If fluoxetine not tolerated |
| Potassium replacement | KCl (Sando-K) | 24-48 mmol daily | Until K+ normalised |
| Proton pump inhibitor | Omeprazole | 20-40mg daily | If significant reflux/oesophagitis |
Key Pharmacotherapy Points:
- Fluoxetine 60mg (higher than depression dose) reduces binge frequency by ~50%
- Onset of effect: 2-4 weeks
- Combine with psychological therapy — medication alone is less effective
- Do NOT use TCAs (seizure risk) or bupropion (contraindicated in eating disorders)
Psychological Management
| Therapy | Description | Evidence |
|---|---|---|
| Bulimia-focused guided self-help | Therapist-supported use of CBT manual | First step; may be sufficient for mild cases |
| CBT-ED | 16-20 sessions structured therapy addressing eating behaviours and cognitions | First-line; 40-50% remission rate |
| Interpersonal Therapy (IPT) | Focus on relationship difficulties | Alternative if CBT declined/unavailable |
| Family-Based Treatment (FBT) | For adolescents; parents take control of eating | Evidence strongest for AN, but used in BN |
Indications for Specialist/Inpatient Care
- Severe electrolyte disturbance not responding to outpatient management
- Severe dehydration or hypotension
- Active suicidal ideation or self-harm
- Failed outpatient treatment (Step 3)
- Comorbid severe depression or substance misuse
- Medical complications (arrhythmias, oesophageal damage)
Disposition
- Most patients: Managed as outpatients in primary care/community eating disorder service
- Specialist referral: If no response to guided self-help after 4 weeks
- Inpatient admission: Medical or psychiatric emergency only
- Follow-up: Weekly initially (monitoring electrolytes if purging); monthly once stable
Immediate (Minutes-Hours)
| Complication | Incidence | Presentation | Management |
|---|---|---|---|
| Oesophageal rupture (Boerhaave) | Rare (less than 0.5%) | Severe chest pain, surgical emphysema, haematemesis | Emergency surgery, broad-spectrum antibiotics |
| Mallory-Weiss tear | 5-10% of frequent purgers | Haematemesis after vomiting | Usually self-limiting; endoscopy if persistent |
| Aspiration pneumonia | Rare | Cough, fever, dyspnoea after vomiting | Antibiotics, respiratory support |
Early (Days-Weeks)
- Hypokalaemia: Muscle weakness, cramps, arrhythmias
- Metabolic alkalosis: From loss of gastric acid (vomiting)
- Metabolic acidosis: From laxative abuse (bicarbonate loss)
- Dehydration: Hypotension, tachycardia, renal impairment
- Dependent oedema: Rebound fluid retention when purging stops
Late (Months-Years)
- Dental caries and erosion: Requires extensive restorative work
- Chronic parotid enlargement: Cosmetically distressing
- Chronic constipation: From laxative dependence (cathartic colon)
- Osteoporosis: Less common than in AN, but occurs with prolonged illness
- Infertility: Ovulatory dysfunction
- Cardiac complications: Cardiomyopathy, mitral valve prolapse
- Chronic oesophagitis/Barrett's oesophagus: Rare but possible
Natural History
- Without treatment: Chronic relapsing course over years to decades
- Spontaneous remission occurs but is uncommon
- Crossover to anorexia nervosa occurs in 10-15%
Outcomes with Treatment
| Variable | Outcome |
|---|---|
| CBT-ED remission | 40-50% at end of treatment |
| Significant improvement | Additional 30% |
| 5-10 year recovery | 50-70% |
| Chronic course | 20-30% |
| Mortality (SMR) | 1.9 (increased vs general population) |
Prognostic Factors
Good Prognosis:
- Younger age at treatment onset
- Shorter duration of illness before treatment
- Good initial response to CBT
- Higher baseline BMI
- Absence of comorbid personality disorder
- Strong social support
Poor Prognosis:
- Long duration of untreated illness (greater than 5 years)
- Comorbid personality disorder (especially borderline)
- Comorbid substance misuse
- History of childhood abuse
- Severe purging frequency
- Previous treatment failure
- Poor insight
Key Guidelines
- NICE NG69 (2017) — Eating disorders: recognition and treatment. Recommends CBT-ED as first-line for bulimia nervosa; fluoxetine 60mg as adjunct. NICE NG69
- RANZCP Clinical Practice Guidelines (2014) — Australian/NZ guidance on eating disorders. RANZCP
- APA Practice Guideline for Eating Disorders (2023) — American Psychiatric Association updated guidance. APA
Landmark Trials
NICE CBT-BN Review (2017) — Systematic review informing NICE guidance
- Multiple RCTs pooled
- Key finding: CBT-ED superior to other psychological therapies and pharmacotherapy alone
- Clinical Impact: Established CBT-ED as gold standard
Fluoxetine Bulimia Nervosa Collaborative Study (1992)
- 387 patients randomised to fluoxetine 20mg, 60mg, or placebo
- Key finding: Fluoxetine 60mg reduced binge frequency by 51% vs 29% placebo
- Clinical Impact: Established high-dose fluoxetine as effective adjunct
Fairburn et al. (2009) — Transdiagnostic CBT for eating disorders (CBT-E)
- Demonstrated that enhanced CBT protocol effective across eating disorder diagnoses
- Clinical Impact: Led to development of CBT-ED as unified treatment approach
Evidence Strength
| Intervention | Level | Key Evidence |
|---|---|---|
| CBT-ED | 1a | Multiple RCTs, Cochrane review |
| Fluoxetine 60mg | 1b | Fluoxetine BN Collaborative Study |
| Guided self-help | 1b | RCTs showing non-inferiority in mild cases |
| IPT | 1b | RCTs showing efficacy similar to CBT long-term |
What is Bulimia Nervosa?
Bulimia nervosa is an eating disorder where a person gets caught in a cycle of eating large amounts of food (called a "binge") and then trying to get rid of the food or its effects (called "purging"). Purging might involve making yourself sick, using laxatives, or exercising excessively. People with bulimia are often a normal weight, which can make the condition harder to spot.
Why does it matter?
Bulimia is not just about food — it is a serious mental health condition that affects your emotional wellbeing and can cause physical harm. Making yourself sick repeatedly can cause your body to lose important minerals, especially potassium, which is vital for your heart. It can also damage your teeth, throat, and digestive system. Many people with bulimia also struggle with depression and anxiety.
How is it treated?
- Talking therapy (CBT): The most effective treatment is a type of therapy called CBT for eating disorders. This helps you understand the thoughts and feelings that lead to binge eating and purging, and develop healthier ways of coping. It usually involves 16-20 sessions.
- Guided self-help: For milder cases, you might start with working through a self-help book or app with some support from a therapist.
- Medication: An antidepressant called fluoxetine (Prozac) at a higher dose can help reduce the urge to binge eat.
- Nutritional advice: Learning to eat regular, balanced meals rather than restricting then binging.
What to expect
- Treatment works for most people — about 40-50% will fully recover, and another 30% will get much better
- It takes time — expect treatment to last 4-6 months at minimum
- Relapses can happen, especially at stressful times, but you can get back on track
- Your physical symptoms (tiredness, bloating) will improve as the binge-purge cycle stops
When to seek help
See a doctor urgently if:
- You feel dizzy, faint, or your heart is racing or skipping beats
- You have blood in your vomit
- You have severe muscle weakness or cramps
- You are having thoughts of harming yourself
- You feel unable to stop purging despite wanting to
Primary Guidelines
- National Institute for Health and Care Excellence. Eating disorders: recognition and treatment (NG69). 2017. NICE NG69
- American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, 5th Edition (DSM-5). 2013.
Key Trials
- Fluoxetine Bulimia Nervosa Collaborative Study Group. Fluoxetine in the treatment of bulimia nervosa. A multicenter, placebo-controlled, double-blind trial. Arch Gen Psychiatry. 1992;49(2):139-147. PMID: 1550466
- Fairburn CG, et al. Transdiagnostic cognitive-behavioral therapy for patients with eating disorders: a two-site trial with 60-week follow-up. Am J Psychiatry. 2009;166(3):311-319. PMID: 19074978
- Hay P, et al. Psychological treatments for bulimia nervosa and binging. Cochrane Database Syst Rev. 2009;(4):CD000562. PMID: 19821271
- Shapiro JR, et al. Bulimia nervosa treatment: a systematic review of randomized controlled trials. Int J Eat Disord. 2007;40(4):321-336. PMID: 17370288
Further Resources
- Beat Eating Disorders (UK): beateatingdisorders.org.uk
- National Eating Disorders Association (US): nationaleatingdisorders.org
- NHS Eating Disorders: nhs.uk/conditions/eating-disorders
Medical Disclaimer: MedVellum content is for educational purposes and clinical reference. Clinical decisions should account for individual patient circumstances. Always consult appropriate specialists for eating disorder management.